Resmed Inc banner

Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 218.53 USD -0.48% Market Closed
Market Cap: $31.7B

Wall St Price Targets

RMD Price Targets Summary
Resmed Inc

Wall Street analysts forecast RMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RMD is 239.7 USD with a low forecast of 176.75 USD and a high forecast of 336 USD.

Lowest Forecast
Price Target
176.75 USD
19% Downside
Average Forecast
Price Target
239.7 USD
10% Upside
Highest Forecast
Price Target
336 USD
54% Upside
Resmed Inc Competitors:
Price Targets

Revenue
Forecast

11% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.

Gross Profit
Forecast

11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 7%.

Operating Income
Forecast

14% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
14% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 8%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 9%.

Net Income
Forecast

14% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
14% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RMD's stock price target?
Price Target
239.7 USD

According to Wall Street analysts, the average 1-year price target for RMD is 239.7 USD with a low forecast of 176.75 USD and a high forecast of 336 USD.

What is the Revenue forecast for Resmed Inc?
Projected CAGR
6%

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.

What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
7%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 7%.

What is the Operating Income forecast for Resmed Inc?
Projected CAGR
8%

Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 8%.

What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
9%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 9%.

What is the Net Income forecast for Resmed Inc?
Projected CAGR
9%

Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett